Works matching AU Chen, Weiming


Results: 118
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Adverse Reaction Reporting for Naxitamab in Chinese Expanded Access Treatment for Relapsed/Refractory High-Risk Neuroblastoma at the Children's Hospital of Fudan University: Adverse Reactions: Naxitamab China Expanded Access: X. Qian et al.

    Published in:
    Drugs - Real World Outcomes, 2025, v. 12, n. 1, p. 115, doi. 10.1007/s40801-024-00468-5
    By:
    • Qian, Xiaowen;
    • Zhang, Dufei;
    • Li, Kai;
    • Chen, Weiming;
    • Zhuang, Peijun;
    • Wang, Hongsheng;
    • Lei, Zhixian;
    • Li, Yan;
    • Eldridge, James;
    • Dong, Kuiran;
    • Zhai, Xiaowen
    Publication type:
    Article
    11
    12

    Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27275-8
    By:
    • Koh, Cho Yeow;
    • Shih, Norrapat;
    • Yip, Christina Y. C.;
    • Li, Aaron Wei Liang;
    • Chen, Weiming;
    • Amran, Fathiah S.;
    • Leong, Esther Jia En;
    • Iyer, Janaki Krishnamoorthy;
    • Croft, Grace;
    • Mazlan, Muhammad Ibrahim Bin;
    • Chee, Yen-Lin;
    • Yap, Eng-Soo;
    • Monroe, Dougald M.;
    • Hoffman, Maureane;
    • Becker, Richard C.;
    • de Kleijn, Dominique P. V.;
    • Verma, Vaishali;
    • Gupta, Amita;
    • Chaudhary, Vijay K.;
    • Richards, A. Mark
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50